GUFICBIOPharmaceuticals
Gufic Biosciences Ltd — Balance Sheet
₹273.80
-4.82%
Gufic Biosciences Ltd Balance Sheet (Annual)
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Ordinary Shares Number | 10.03 Cr | 10.03 Cr | 9.69 Cr | 9.69 Cr | — |
| Share Issued | 10.03 Cr | 10.03 Cr | 9.69 Cr | 9.69 Cr | — |
| Net Debt | 294.65 Cr | 315.90 Cr | 282.81 Cr | 49.63 Cr | — |
| Total Debt | 336.19 Cr | 332.92 Cr | 334.19 Cr | 64.39 Cr | — |
| Tangible Book Value | 594.73 Cr | 526.94 Cr | 347.13 Cr | 268.51 Cr | — |
| Invested Capital | 911.45 Cr | 849.60 Cr | 659.22 Cr | 330.36 Cr | — |
| Working Capital | 236.97 Cr | 228.43 Cr | 175.90 Cr | 134.35 Cr | — |
| Net Tangible Assets | 594.73 Cr | 526.94 Cr | 347.13 Cr | 268.51 Cr | — |
| Capital Lease Obligations | 25.82 Cr | 15.88 Cr | 22.79 Cr | 3.15 Cr | — |
| Common Stock Equity | 601.08 Cr | 532.56 Cr | 347.81 Cr | 269.12 Cr | — |
| Total Capitalization | 731.58 Cr | 686.52 Cr | 538.49 Cr | 317.10 Cr | — |
| Total Equity Gross Minority Interest | 601.08 Cr | 532.56 Cr | 347.81 Cr | 269.12 Cr | — |
| Minority Interest | 0.00 | 0.00 | — | — | — |
| Stockholders Equity | 601.08 Cr | 532.56 Cr | 347.81 Cr | 269.12 Cr | — |
| Other Equity Interest | 591.05 Cr | 522.53 Cr | 338.11 Cr | 259.42 Cr | — |
| Capital Stock | 10.03 Cr | 10.03 Cr | 9.69 Cr | 9.69 Cr | — |
| Common Stock | 10.03 Cr | 10.03 Cr | 9.69 Cr | 9.69 Cr | — |
| Total Liabilities Net Minority Interest | 568.29 Cr | 559.98 Cr | 513.35 Cr | 252.28 Cr | — |
| Total Non Current Liabilities Net Minority Interest | 180.73 Cr | 187.93 Cr | 225.14 Cr | 65.88 Cr | — |
| Other Non Current Liabilities | 1000.00 | — | — | -1000.00 | — |
| Non Current Deferred Taxes Liabilities | 7.77 Cr | 2.06 Cr | 0.00 | 0.19 Cr | — |
| Long Term Debt And Capital Lease Obligation | 150.09 Cr | 165.52 Cr | 206.89 Cr | 48.31 Cr | — |
| Long Term Capital Lease Obligation | 19.59 Cr | 11.56 Cr | 16.21 Cr | 0.33 Cr | — |
| Long Term Debt | 130.50 Cr | 153.96 Cr | 190.68 Cr | 47.98 Cr | — |
| Long Term Provisions | 17.49 Cr | 15.38 Cr | 13.29 Cr | 12.39 Cr | — |
| Current Liabilities | 387.56 Cr | 372.05 Cr | 288.21 Cr | 186.40 Cr | — |
| Other Current Liabilities | 23.11 Cr | 17.36 Cr | 12.50 Cr | 12.39 Cr | — |
| Current Debt And Capital Lease Obligation | 186.10 Cr | 167.40 Cr | 127.30 Cr | 16.08 Cr | — |
| Current Capital Lease Obligation | 6.23 Cr | 4.33 Cr | 6.58 Cr | 2.82 Cr | — |
| Current Debt | 179.88 Cr | 163.07 Cr | 120.73 Cr | 13.26 Cr | — |
| Current Provisions | 4.40 Cr | 4.74 Cr | 4.24 Cr | 4.87 Cr | — |
| Payables | 158.75 Cr | 193.52 Cr | 148.18 Cr | 158.74 Cr | — |
| Total Tax Payable | 0.00 | 2.55 Cr | 3.12 Cr | 0.67 Cr | — |
| Accounts Payable | 158.75 Cr | 166.27 Cr | 130.26 Cr | 140.95 Cr | — |
| Total Assets | 1.17K Cr | 1.09K Cr | 861.16 Cr | 521.40 Cr | — |
| Total Non Current Assets | 544.84 Cr | 492.06 Cr | 397.05 Cr | 200.65 Cr | — |
| Other Non Current Assets | 5.29 Cr | 15.05 Cr | 57.71 Cr | 1000.00 | — |
| Investmentin Financial Assets | 11.52 Cr | 1.78 Cr | 0.78 Cr | 75000.00 | — |
| Available For Sale Securities | 11.52 Cr | 0.78 Cr | 0.78 Cr | 75000.00 | — |
| Goodwill And Other Intangible Assets | 6.34 Cr | 5.62 Cr | 0.68 Cr | 0.61 Cr | — |
| Net PPE | 521.46 Cr | 474.17 Cr | 328.48 Cr | 155.43 Cr | — |
| Gross PPE | 521.46 Cr | 560.38 Cr | 414.38 Cr | 219.33 Cr | — |
| Construction In Progress | 21.82 Cr | 320.89 Cr | 169.59 Cr | 40.87 Cr | — |
| Other Properties | 499.65 Cr | 5.46 Cr | 5.46 Cr | 4.74 Cr | — |
| Current Assets | 624.52 Cr | 600.48 Cr | 464.11 Cr | 320.75 Cr | — |
| Other Current Assets | 62.13 Cr | 2.89 Cr | 0.84 Cr | 40000.00 | — |
| Inventory | 216.87 Cr | 200.48 Cr | 183.46 Cr | 115.57 Cr | — |
| Other Receivables | 0.32 Cr | 0.37 Cr | 0.20 Cr | 0.38 Cr | — |
| Taxes Receivable | 1.57 Cr | — | 0.00 | 0.00 | 0.00 |
| Accounts Receivable | 314.61 Cr | 329.94 Cr | 205.47 Cr | 151.55 Cr | — |
| Cash Cash Equivalents And Short Term Investments | 29.02 Cr | 1.14 Cr | 28.60 Cr | 11.61 Cr | — |
| Other Short Term Investments | 13.30 Cr | 12.35 Cr | 18.08 Cr | 14.96 Cr | — |
| Cash And Cash Equivalents | 15.72 Cr | 1.14 Cr | 28.60 Cr | 11.61 Cr | — |
| Retained Earnings | — | 352.46 Cr | 267.29 Cr | 188.55 Cr | 93.68 Cr |
| Additional Paid In Capital | — | 99.66 Cr | — | — | — |
| Non Current Deferred Revenue | — | 4.97 Cr | 4.96 Cr | 5.00 Cr | 5.00 Cr |
| Current Deferred Taxes Liabilities | — | 2.55 Cr | 3.12 Cr | 0.67 Cr | 1.58 Cr |
| Other Payable | — | 27.24 Cr | 17.89 Cr | 17.69 Cr | 20.14 Cr |
| Dividends Payable | — | 0.02 Cr | 0.02 Cr | 0.10 Cr | 0.05 Cr |
| Non Current Prepaid Assets | — | 10.08 Cr | 65.80 Cr | 44.36 Cr | 12.28 Cr |
| Non Current Deferred Taxes Assets | — | 0.00 | 0.97 Cr | 0.00 | 0.00 |
| Held To Maturity Securities | — | 1.00 Cr | — | — | — |
| Other Intangible Assets | — | 5.62 Cr | 0.68 Cr | 0.61 Cr | 0.45 Cr |
| Accumulated Depreciation | — | -86.21 Cr | -85.90 Cr | -63.90 Cr | -48.21 Cr |
| Machinery Furniture Equipment | — | 146.19 Cr | 147.94 Cr | 118.20 Cr | 107.46 Cr |
| Buildings And Improvements | — | 77.94 Cr | 91.39 Cr | 55.51 Cr | 35.80 Cr |
| Land And Improvements | — | 9.89 Cr | — | 6.30 Cr | 0.00 |
| Properties | — | 0.00 | 0.00 | 0.00 | 0.00 |
| Restricted Cash | — | 12.35 Cr | 18.08 Cr | 14.96 Cr | 6.98 Cr |
| Prepaid Assets | — | 53.31 Cr | 27.46 Cr | 26.68 Cr | 28.14 Cr |
| Finished Goods | — | 48.38 Cr | 46.84 Cr | 50.46 Cr | 23.62 Cr |
| Work In Process | — | 55.28 Cr | 57.39 Cr | 20.45 Cr | 28.23 Cr |
| Raw Materials | — | 96.83 Cr | 79.23 Cr | 44.65 Cr | 42.55 Cr |
| Allowance For Doubtful Accounts Receivable | — | -5.59 Cr | -4.38 Cr | -4.44 Cr | -3.04 Cr |
| Gross Accounts Receivable | — | 335.52 Cr | 209.85 Cr | 155.99 Cr | 127.54 Cr |
| Cash Financial | — | 1.14 Cr | 28.60 Cr | 11.61 Cr | 6.20 Cr |
| Goodwill | — | — | 0.00 | 0.00 | 0.00 |
| Other Inventories | — | — | — | 1000.00 | — |
All figures in ₹ Crores. Source: NSE/BSE filings via Bull Run.
More on Gufic Biosciences Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.